News
-
AHPRA ad compliance strategy
Friday | Apr 21 2017THE Pharmacy Board of Australia and the Australian Health Practitioner Regulation Agency has published a new "Advertising compliance and enforcement strategy," with the document detailing the management of advertising complaints and the regulatory powers available to deal with breaches of the National Law.
-
API forecasts 10% uplift
Friday | Apr 21 2017AUSTRALIAN Pharmaceutical Industries says despite fragile consumer confidence it continues to expect its full year profit after tax to increase by 10% this year.
-
Dispensary Corner 20 Apr 17
Thursday | Apr 20 2017A hankering for hygiene has left two Danish tourists visiting Rome a little lighter in the pocket, after they were arrested for washing their feet in one of the city's public fountains.
-
Zydelig advisory
Thursday | Apr 20 2017IDELALISIB, marketed in Australia as Zydelig, should no longer be used in combination with rituximab in specific situations, according to a safety review conducted by the Therapeutic Goods Administration.
-
Somalia vax campaign
Thursday | Apr 20 2017GAVI, the private-public Vaccine Alliance, sponsored by private organisations and governments across the world, has delivered 953,000 doses of Oral Cholera Vaccine to Somalia.
-
Span-K recall
Thursday | Apr 20 2017ASPEN Pharmacare, in consultaion with the Therapeutic Goods Administration, has initiated a recall for product correction of its Span-K (potassium chloride) 600mg tablets.
-
Aftstyla approved
Thursday | Apr 20 2017CSL Behring has announced that the Australian Therapeutic Goods Administration has approved Afstyla (lonoctocog alfa) a recombinant single chain coagulation factor VIII (rFVIIISingleChain) in patients with haemophilia A (congenital factor VIII deficiency).
-
Pharmac rejection
Thursday | Apr 20 2017NZ'S Pharmac medicines authority has rejected a bid to fund feminine hygiene products such as tampons and sanitary pads.
-
Merck $150k award
Thursday | Apr 20 2017MERCK has announced a two year $150,000 fellowship award to support Australian clinical research into gastrointestinal cancer.